Skip to main content

Table 2 FCGRIIB rs1050501 genotypes and corresponding anti-HSV1 IgG antibody index in AD patients, MCI subjects, and healthy controls

From: Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer’s disease

 

FCGRIIB rs1050501 genotypes (%)

HSV-1 Ab IgG (AI)

HSV-1 IgG1 (OD)

HSV-1 IgG2 (OD)

HSV-1 IgG3 (OD)

HSV-1 IgG4 (OD)

AD (no 69)

TT (74.2)

8.94; 7.17–10.50

2.06; 1.47–2.56

0.95; 0.76–1.14

0.65; 0.49–0.78

0.59; 0.58–0.72

CT (22.7)

8.78; 7.22–9.33

2.23; 1.13–2.44

0.75; 0.75–0.75

0.69; 0.49–0.86

0.58; 0.57–1.38

CC (3.1)

7.60; 5.5–9.71

3.18; 3.18–3.18

0.46; 0.46–0.46

MCI (no 52)

TT (74.5)

8.82; 7.1–10.96

2.03; 1.68–2.60

0.66; 0.53-0.80

0.75; 0.47-0.95

0.58; 0.56–0.82

CT (21.6)

8.03; 5.25–10.99

2.31; 2.02–3.07

0.61; 0.48–0.77

0.6; 0.57–1.04

CC (3.9)

10.77; 8.85–12.7

2.29; 1.99–2.59

0.44; 0.42–0.47

HC (no 49)

TT (79.2)

7.53; 6.12–8.83

2.56; 1.98–2.99

0.62; 0.53–0.72

0.58; 0.54–1.81

CT (18.7)

6.29; 5.60–7.74

2.46; 1.49–2.94

0.89; 0.36–1.17

1.02; 0.68–1.48

CC (2.1)

7.47; 7.47–7.47

3.12; 3.12–3.12

0.55; 0.55–0.55

  1. Data are reported as median; Interquartile range
  2. AD Alzheimer’s disease, MCI Mild Cognitive Impairment, AI antibody index, OD optical density